Deck 52: Men As Patients
سؤال
سؤال
سؤال
سؤال
سؤال
سؤال
سؤال
سؤال
سؤال
سؤال
فتح الحزمة
قم بالتسجيل لفتح البطاقات في هذه المجموعة!
Unlock Deck
Unlock Deck
1/10
العب
ملء الشاشة (f)
Deck 52: Men As Patients
1
When assessing a male for hypogonadism prior to prescribing testosterone replacement, serum testosterone levels are drawn:
A)Without regard to time of day
B)First thing in the morning
C)Late afternoon
D)In the evening
A)Without regard to time of day
B)First thing in the morning
C)Late afternoon
D)In the evening
First thing in the morning
2
While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
A)Hemoglobin 14 g/dL or hematocrit 39%
B)Hemoglobin 11.5 g/dL or hematocrit 31%
C)Hemoglobin 13 g/dL or hematocrit 38%
D)Hemoglobin 17.5 g/dL or hematocrit 54%
A)Hemoglobin 14 g/dL or hematocrit 39%
B)Hemoglobin 11.5 g/dL or hematocrit 31%
C)Hemoglobin 13 g/dL or hematocrit 38%
D)Hemoglobin 17.5 g/dL or hematocrit 54%
Hemoglobin 17.5 g/dL or hematocrit 54%
3
When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of:
A)Statins
B)Nitrates
C)Insulin
D)Opioids
A)Statins
B)Nitrates
C)Insulin
D)Opioids
Nitrates
4
Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?
A)Age-related decrease in cognitive functioning
B)Metabolic syndrome
C)Decreased muscle mass in aging men
D)All of the above
A)Age-related decrease in cognitive functioning
B)Metabolic syndrome
C)Decreased muscle mass in aging men
D)All of the above
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
5
Male patients who should not be prescribed PDE-5 inhibitors include:
A)Diabetics
B)Those who have had an acute myocardial infarction in the past six months
C)Those who are deaf
D)Those who are under age 60 years of age
A)Diabetics
B)Those who have had an acute myocardial infarction in the past six months
C)Those who are deaf
D)Those who are under age 60 years of age
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
6
The factor that has the greatest effect on males developing male sexual characteristics is:
A)Cultural beliefs
B)Effective male role models
C)Adequate intake of testosterone in the diet
D)Androgen production
A)Cultural beliefs
B)Effective male role models
C)Adequate intake of testosterone in the diet
D)Androgen production
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
7
Monitoring of male patients who are using PDE-5 inhibitors includes:
A) Serum fasting glucose levels
B) Cholesterol and lipid levels
C) Blood pressure
D) Complete blood count
A) Serum fasting glucose levels
B) Cholesterol and lipid levels
C) Blood pressure
D) Complete blood count
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
8
Men who are prescribed PDE-5 inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug, which include:
A)Hearing loss
B)Prostate enlargement
C)Delayed ejaculation
D)Dizziness
A)Hearing loss
B)Prostate enlargement
C)Delayed ejaculation
D)Dizziness
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
9
The goal of testosterone replacement therapy is:
A)Absence of all hypogonadism symptoms
B)Testosterone levels in the mid-normal range one week after an injection
C)Testosterone levels in the mid-normal range just prior to the next injection
D)Avoidance of high serum testosterone levels during therapy
A)Absence of all hypogonadism symptoms
B)Testosterone levels in the mid-normal range one week after an injection
C)Testosterone levels in the mid-normal range just prior to the next injection
D)Avoidance of high serum testosterone levels during therapy
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck
10
Monitoring of an older male patient on testosterone replacement includes:
A)Oxygen saturation levels at every visit
B)Serum cholesterol and lipid profile every 3 to 6 months
C)Digital rectal prostate screening exam at three and six months after starting therapy
D)Bone mineral density at three and six months after starting therapy
A)Oxygen saturation levels at every visit
B)Serum cholesterol and lipid profile every 3 to 6 months
C)Digital rectal prostate screening exam at three and six months after starting therapy
D)Bone mineral density at three and six months after starting therapy
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 10 في هذه المجموعة.
فتح الحزمة
k this deck

